A Call for Transparency, Improved Reporting and Interpretation of Trials Using Surrogate Endpoints in Cardiac Electrophysiology

By sjmartinez • March 2, 2025

Tereshchenko LG, Manyara AM, Ciani O, Sodeke SO, Bradford CN, Santangeli P, Kapadia SR, Wazni O, Narayan SM, Chugh SS, Bilchick K, Huizar JF, Vaseghi M, Chung MK, Ellenbogen KA, Taylor RS. A Call for Transparency, Improved Reporting and Interpretation of Trials Using Surrogate Endpoints in Cardiac Electrophysiology. Heart Rhythm. 2025 Feb 26:S1547-5271(25)00209-7. doi: 10.1016/j.hrthm.2025.02.038. Epub ahead of print. PMID: 40021073.

Tags: Biomarker, Cardiology/Epi, Checklist, Clinical Trial, Outcome, Publications, Randomized Controlled Trial, Research design, standards, surrogate endpoint, surrogate marker

Association of a Comprehensive ST-Segment-Elevation Myocardial Infarction Protocol With Key Process Metrics Amocg Patients Transferred for Primary Percutaneous Coronary Intervention

Zinoviev R, Kumar A, Huded CP, Johnson M, Kravitz K, Reed GW, Krishnaswamy A, Kralovic DM, Hustey FM, Brown AS, Kapadia SR, Khot UN. Association[...]

Viscoelastic extracellular matrix enhances epigenetic remodeling and cellular plasticity

Wu Y, Song Y, Soto J, Hoffman T, Lin X, Zhang A, Chen S, Massad RN, Han X, Qi D, Yeh KW, Fang Z, Eoh[...]

Proactive Electrophysiological Mapping and Ablation to Prevent Ventricular Tachycardia in Repaired Tetralogy of Fallot

Meyer C, Shivkumar K. Proactive Electrophysiological Mapping and Ablation to Prevent Ventricular Tachycardia in Repaired Tetralogy of Fallot. J Am Coll Cardiol. 2025 May 6;85(17):1706-1708.[...]